Mitchell P. Kopin 13D and 13G filings for Enveric Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 11:18 am Purchase | 2024-09-30 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 19,333 3.100% | 9,667 (+100.00%) | Filing |
| 2024-02-06 10:17 am Sale | 2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 9,667 6.200% | -4,076 (-29.66%) | Filing |
| 2023-02-08 06:06 am Purchase | 2022-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 13,742 9.400% | 13,742 (New Position) | Filing |